According to the scientific Council, “it is critical to develop a strategy national immunisation” to be ready as soon as a vaccine becomes available.
The possibility that a vaccine against the Covid-19 can be available and administered to millions of people, particularly health professionals, must be prepared as early as now, according to the Scientific Council. Many trials are ongoing, and although the use of a vaccine will be subject to the “uncertainties and unknown scientists (effectiveness, availability in the medium or long term, type of vaccines…), it is now crucial to develop a strategy national immunisation” to integrate it effectively in the fight against the epidemic, as soon as it becomes available, according to the opinion of the Council, released this Friday.
READ ALSO >> Covid-19 : what we know about the huge pre-order for a future vaccine Washington
The French government negotiates (in partnership with its european counterparts) of contracts booking of vaccines which we do not yet know the characteristics (effectiveness against the infection, transmission, number of injections, with or without callback…). “But it is expected to be several tens of millions of doses of vaccines (potentially corresponding to 2 to 5 different products) are available between the last quarter of the year is 2020 and the first quarter of 2021, which could be deployed if there is a second wave of Covid-19”.
summer Offer : Take advantage of the special offer 2 months for 1€ I subscribe
The experts deem “imperative to give the time necessary for a rigorous evaluation” of the effectiveness and safety of candidate vaccines prior to their use on a large scale”. The government, according to the nature of the vaccine or vaccines available, will need to determine “who to vaccinate and how,” stressed the opinion that advocates of involving citizens in this process of preparation, in order not to renew the failure of the anti-influenzal vaccination of 2009.
Targeting of priority populations
The Council rejects the idea of”compulsory vaccination”, calling the vaccination “organized”. Once known, the characteristics of the vaccine will enable France to make the best choice based on the needs identified (in the form of a single dose more easily usable in medical offices, or in multi-dose vials…). “The targeting of priority populations is crucial,” according to the document.
READ ALSO >> The offensive digital anti-vaccines
Among the priority populations in France (Overseas included), are approximately 6.8 million people at risk of occupational exposure with a “very high priority” for about 1.8 million of them, mainly health professionals. In this group, include around 5 million people at “high priority” exposed to through their employment at the contact of the population (merchants, home-based care workers, teachers, bus drivers) or who work in environments that are confined to risk (slaughterhouses, taxis/VTC, cruises..) or with a accommodation confined to risk (migrant workers, construction site…).
Read our complete file
“Covid-19”, the new coronavirus
Covid-19 : the obligation of wearing a mask outdoors is it really useful ? Coronavirus: the Catalonia closes the nightclubs, the curfew for restaurants Covid-19 : viral circulation is “net increase” in France
people at risk because of their age or their state of health, about 23 million people in France and those in precarious (about 250,000 people) constitute the other group of the priority populations in the first place, according to the notice. The notice comes from the reflection of a group made up of members of the Committee on Analytical Research Expertise (Care) Covid-19, the scientific Committee on vaccine Covid-19 and of the scientific Council Covid-19.
